Skip to main content

MoneyWorks4Me

Nifty Healthcare Index Companies

BSE Sensex 82724.79 620 (0.76%)

See MoneyWorks4me's rating on Quality, Valuation, Price Trend and Overall Rating to take informed stock investing decisions. Decizen :- Q: Quality, V: Valuation, PT: Price Trend

Nifty Healthcare Index companies as on Nov-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks
Company Name
DeciZen
CMP
Price
Change (%)
Market
Cap (Cr)
52Week
High
52Week
Low
ROE(%)
P/E
P/BV
EV/
EBITDA
5Y Sales
Gr.(%)
5Y Profit
Gr.(%)
1
Q V+ PT
2,336 5.38% 1,30,756
Mid Cap
2,482
11 Nov, 26
913
02 Feb, 26
17.86 97.59 21.57 55.03 7.19 -2.25
2
Q V PT
1,205 1.38% 1,18,803
Mid Cap
1,266
04 Nov, 26
836
02 Apr, 26
17.64 28.42 4.27 15.04 13.52 14.72
3
Q V PT
1,022 1.22% 91,979
Mid Cap
1,187
24 Nov, 25
797
22 Oct, 26
14.68 66.62 8.12 35.99 27.27 155.29
4
Q V PT
5,185 0.88% 61,098
Mid Cap
5,933
13 Jan, 26
4,880
22 Oct, 26
18.04 29.55 4.11 16.55 10.66 8.92
5
Q V PT
1,387 0.50% 1,15,017
Mid Cap
1,414
29 Jun, 26
1,080
23 Jul, 26
10.90 41.08 2.96 19.17 12.09 15.75
6
Q V+ PT
1,875 0.43% 4,51,291
Large Cap
2,048
31 Jul, 26
1,584
29 Jan, 26
14.80 41.15 5.05 21.32 11.78 14.41
7
Q V+ PT
1,795 0.37% 1,05,237
Mid Cap
1,857
11 Nov, 26
1,106
10 Feb, 26
10.64 38.48 4.50 26.41 -6.73 -4.90
8
Q V+ PT
11,146 0.32% 3,05,014
Large Cap
11,818
09 Nov, 26
5,648
02 Apr, 26
15.58 90.70 16.95 60.00 8.67 4.44
9
Q V+ PT
8,782 0.29% 1,22,440
Large Cap
9,327
03 Aug, 26
6,680
28 Jan, 26
16.08 75.26 11.43 42.26 14.92 0.00
10
Q V+ PT
803 0.21% 57,754
Mid Cap
1,010
10 Jun, 26
705
23 Oct, 26
11.22 55.62 5.51 26.85 17.76 0.00
11
Q V PT
25,999 0.18% 56,127
Mid Cap
30,598
25 Nov, 25
24,670
23 Oct, 26
34.24 33.96 13.14 23.49 9.96 17.33
12
Q V PT
2,623 -0.09% 1,09,622
Mid Cap
2,705
09 Nov, 26
1,910
23 Mar, 26
12.76 48.88 6.23 25.83 18.10 8.40
13
Q V PT
1,390 -0.28% 1,12,539
Large Cap
1,539
06 Jan, 26
1,166
02 Apr, 26
11.57 38.85 3.18 19.95 8.01 10.07
14
Q V PT
762 -0.33% 30,644
Small Cap
858
06 Jul, 26
576
27 Jan, 26
11.38 144.27 7.79 35.24 24.04 3.67
15
Q V PT
360 -0.54% 59,777
Mid Cap
447
16 Jul, 26
319
23 Oct, 26
0.71 504.45 2.18 104.69 2.96 -18.61
16
Q V+ PT
2,614 -0.56% 74,592
Mid Cap
2,714
09 Nov, 26
1,811
17 Nov, 25
27.89 51.40 6.65 20.59 9.19 22.19
17
Q V+ PT
4,650 -0.85% 1,77,333
Large Cap
5,250
03 Aug, 26
3,675
21 Nov, 25
29.04 83.49 9.65 33.26 11.80 13.74
18
Q V PT
1,954 -0.96% 90,544
Mid Cap
2,530
16 Jul, 26
1,893
23 Oct, 26
26.43 17.39 3.76 9.50 13.02 32.37
19
Q V+ PT
1,831 -1.89% 47,828
Mid Cap
2,039
22 Sep, 26
1,363
30 Dec, 25
16.05 36.06 5.58 22.10 7.35 1.36
20
Q V PT
3,287 -2.72% 55,026
Mid Cap
3,428
16 Nov, 26
1,575
16 Mar, 26
10.05 44.52 5.15 23.27 13.18 0.09

Nifty Healthcare Index - Today's Top Gainers

Company Name CMP Price Change(%)
2,336.40 5.38%
1,205.40 1.38%
1,022.35 1.22%
5,185.30 0.88%
1,386.95 0.50%

Nifty Healthcare Index - Today's Top Losers

Company Name CMP Price Change(%)
3,287.25 -2.72%
1,831.40 -1.89%
1,953.55 -0.96%
4,650 -0.85%
2,614.25 -0.56%

News about Nifty Healthcare Index

All Indices

Nifty Healthcare Index FAQs

You can use different criterias to arrive at the list of best stocks in the Nifty Healthcare Index company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Healthcare Index companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Abbott India Ltd. (M) Very Good 25,999 56,127 33.96 13.14 23.49 34.24
Torrent Pharmaceuticals Ltd. (L) Very Good 4,650 1,77,333 83.49 9.65 33.26 29.04
Glenmark Pharmaceuticals Ltd. (M) Very Good 2,614 74,592 51.40 6.65 20.59 27.89
Lupin Ltd. (M) Somewhat Good 1,954 90,544 17.39 3.76 9.50 26.43
Alkem Laboratories Ltd. (M) Very Good 5,185 61,098 29.55 4.11 16.55 18.04

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Laurus Labs Ltd. (M) Very Good 2,336 1,30,756 122
Gland Pharma Ltd. (M) Very Good 3,287 55,026 84.56
Divis Laboratories Ltd. (L) Very Good 11,146 3,05,014 70.64
Aurobindo Pharma Ltd. (M) Very Good 1,795 1,05,237 46.33
Glenmark Pharmaceuticals Ltd. (M) Very Good 2,614 74,592 38.55
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Max Healthcare Institute Ltd. (M) N/A 1,022 91,979 66.62 8.12 35.99 27.27
Krishna Institute of Medical Sciences Ltd. (S) Very Good 762 30,644 144 7.79 35.24 24.04
Mankind Pharma Ltd. (M) Very Good 2,623 1,09,622 48.88 6.23 25.83 18.10
Fortis Healthcare Ltd. (M) Very Good 803 57,754 55.62 5.51 26.85 17.76
Apollo Hospitals Enterprise Ltd. (L) Somewhat Good 8,782 1,22,440 75.26 11.43 42.26 14.92

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Max Healthcare Institute Ltd. (M) N/A 1,022 91,979 66.62 8.12 35.99 155
Lupin Ltd. (M) Somewhat Good 1,954 90,544 17.39 3.76 9.50 32.37
Glenmark Pharmaceuticals Ltd. (M) Very Good 2,614 74,592 51.40 6.65 20.59 22.19
Abbott India Ltd. (M) Very Good 25,999 56,127 33.96 13.14 23.49 17.33
Dr. Reddys Laboratories Ltd. (M) Very Good 1,387 1,15,017 41.08 2.96 19.17 15.75
You’ve reached your free data limit. Unlock unlimited data views for free. Login | Register Now

About MoneyWorks4Me

MoneyWorks4Me has been helping investors make better investment decisions since 2008.

MoneyWorks4Me Investment Advisers is the trade/brand name of The Alchemists Ark Pvt. Ltd., a SEBI-registered non-individual Investment Adviser (Registration No. INA000013323).

We began in 2008 as an equity research company, helping investors identify high-quality Indian businesses and understand what they were worth through deep fundamental research and intrinsic-value-based investing.

Over time, we learnt that successful investing requires much more than identifying good stocks.

Investors also need to know how much to invest, how to allocate money across different assets, how to construct a strong portfolio, when to act and, equally importantly, when not to.

That understanding shaped our evolution from an equity research company into a broader investment company built around research, portfolio strategy, technology and human judgement.

One Investing Philosophy. Different Ways to Benefit From It.

Today, our capabilities extend across Indian direct equities, mutual funds, global equities, fixed income, gold and REITs and other suitable investment opportunities.

We do not see these as separate investment products. They are different building blocks of one portfolio.

The starting point is the investor: their goals, required returns, time horizon, ability to take risk and the role each asset needs to play.

Asset allocation determines where the money should go.Research and valuation guide what we own. Portfolio construction determines how much we own.Periodic review and rebalancing help keep the portfolio aligned with its purpose.

This investment philosophy is applied in different ways across MoneyWorks4Me.

Through Omega Freedom and Omega Legacy, we work closely with investors who want comprehensive investment advice and guidance in managing their portfolios.

Through Third Rock Wealth, we bring the same investment thinking and research depth to investors who prefer mutual funds as their route to wealth creation.

Research at the Core

We look at business quality, financial strength, competitive advantage, management, growth prospects and risks. But we always consider these alongside valuation.

A good company does not automatically make a good investment at every price.

Our Quality-at-a-Reasonable-Price approach seeks to bring quality and valuation together.

Start With the Portfolio

We do not begin by asking which stock, fund or asset looks attractive.

We begin by asking what the portfolio needs.

Indian equities may provide long-term growth. Global equities can broaden diversification. Fixed income can provide stability and liquidity. Gold has a different role to play.

Every investment should earn its place in the portfolio.

Focus on Process, Not Prediction

Markets cannot be predicted consistently. A sound investment process can be followed consistently.

We therefore focus on what can be controlled: asset allocation, quality, valuation, diversification, position sizing, risk management, review and taking action when required.

Let Compounding Do the Heavy Lifting

Long-term wealth is not created only by finding investments with spectacular returns.

It comes from putting money to work intelligently, earning satisfactory inflation-beating returns across the portfolio and staying invested long enough for compounding to make a meaningful difference.

Technology Has Always Been Part of MoneyWorks4Me

Technology has been integral to MoneyWorks4Me from the beginning, from our financial X-Rays and valuation tools to portfolio analytics and research systems.

Over the years, we have accumulated company research, financial data, valuation work, investment frameworks and insights.

The aim is to make it easier for investors and our teams to work with years of MoneyWorks4Me research, data and investment thinking.

It is not intended to replace human judgement.

Investing still involves context, uncertainty and decisions for which there is not always an obvious answer.

Investors Should Understand Why

Our advisory business operates in a fiduciary capacity, and the investor's interests come first.

We believe investors should understand the reasoning behind important investment decisions rather than simply follow recommendations.

That is the thinking behind our Do-It-With-Me approach.

It is designed to help investors remain in control of their money while benefiting from professional research, process and perspective.

Our Vision

Our vision is to build a trusted, research-powered investment company that helps investors make calm, informed and well-reasoned decisions throughout their investing journey.

Markets will change. Investment opportunities will change. Technology will change how investors access information and advice.

But the principles of successful investing are far more enduring:own quality assets at sensible prices, build portfolios intelligently, manage risk and give compounding enough time to work.

That is the investment discipline MoneyWorks4Me has been building since 2008 and continues to strengthen for the future.